Estimation of The Percentage of US Patients With Cancer Who Benefit From Genome-Driven Oncology | Oncology | JAMA Oncology | JAMA Network

Estimation of The Percentage of US Patients With Cancer Who Benefit From Genome-Driven Oncology | Oncology | JAMA Oncology | JAMA Network

Original Investigation

April 17, 2018

Estimation of The Percentage of US Patients With Cancer Who Benefit From Genome-Driven Oncology

John Marquart, BA¹; Emerson Y. Chen, MD²; Vinay Prasad, MD, MPH^2,3,4

Author Affiliations Article Information

JAMA Oncol. Published online April 17, 2018. doi:10.1001/jamaoncol.2018.1660